{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:09:54Z","timestamp":1789099794641,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Preventing varicella-zoster virus infection is important in the management of human immunodeficiency virus (HIV)-positive persons. Varicella remains endemic worldwide, and HIV-positive persons can experience greater morbidity than the general population. We summarized the global literature on the safety and immunogenicity of the varicella vaccine in HIV-positive children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Systematic review of original reports on varicella vaccination of HIV-positive children, published through December 31, 2024, including assessment of safety, immunologic responses and effectiveness after vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eighteen articles were analyzed. Local reactions were the most common adverse events, albeit infrequent (&lt;21% and &lt;10% of vaccinees after dose 1 and 2, respectively). Systemic reactions were also infrequent, consisting mostly of low-grade fever. A vaccine-related rash, reported in &lt;5% of vaccinees, had fewer lesions and a shorter duration than typical varicella. Serious adverse events were reported only when the vaccine was inadvertently administered to children with severe HIV immunosuppression. Varicella vaccination had no clinically significant impact on plasma HIV RNA or CD4+ T-cell count after either dose. An antibody response was reported in 60%\u201379% of HIV-positive vaccinees after dose 2 and often declined more rapidly than in uninfected children. Cell-mediated immunity was detected in 67%\u201383% after dose 2. No significant differences in adverse events or short-term immune response after vaccination correlated with past or current CD4+ T-cell status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The varicella vaccine had a favorable safety profile and induced specific immune responses in most nonseverely immunocompromised HIV-positive children. The vaccine remains contraindicated for persons with severe HIV infection. Robust data on the durability of immune response and long-term effectiveness are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005264","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:00:47Z","timestamp":1778472047000},"page":"916-924","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-0511","authenticated-orcid":false,"given":"Mona","family":"Marin","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2959-211X","authenticated-orcid":false,"given":"Likhita","family":"Raparti","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"ASRT Inc., Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-7555","authenticated-orcid":false,"given":"Jessica","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1587-9551","authenticated-orcid":false,"given":"Sara E.","family":"Oliver","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7468-106X","authenticated-orcid":false,"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0031-3955(05)70196-6","article-title":"Opportunistic infections and other clinical manifestations of HIV disease in children.","volume":"47","author":"Abrams","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"key":"R4-20260911","first-page":"32","article-title":"Prevention and treatment of VZV infections in patients with HIV.","volume":"8","author":"Gershon","year":"2001","journal-title":"Herpes"},{"key":"R6-20260911","first-page":"742","article-title":"Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children.","volume":"147","author":"Srugo","year":"1993","journal-title":"Am J Dis Child"},{"key":"R7-20260911","first-page":"27","article-title":"Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature.","volume":"49","author":"Leibovitz","year":"1992","journal-title":"Cutis"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection.","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(96)70427-4","article-title":"Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1.","volume":"128","author":"von Seidlein","year":"1996","journal-title":"J Pediatr"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/21.2.370","article-title":"Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.","volume":"21","author":"Glesby","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/archopht.1993.01090120029011","article-title":"Acute retinal necrosis after chickenpox in a patient with acquired immunodeficiency syndrome.","volume":"111","author":"Friedman","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/516285","article-title":"Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS.","volume":"26","author":"Ormerod","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/QAI.0b013e31819550a4","article-title":"Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.","volume":"50","author":"Levin","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/peds.2007-0564","article-title":"Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.","volume":"121","author":"Wood","year":"2008","journal-title":"Pediatrics"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection.","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella.","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"R17-20260911","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP).","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM199605093341903","article-title":"Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.","volume":"334","author":"Stanley","year":"1996","journal-title":"N Engl J Med"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/QAD.0000000000001201","article-title":"Standard vaccines increase HIV-1 transcription during antiretroviral therapy.","volume":"30","author":"Yek","year":"2016","journal-title":"AIDS"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?","volume":"265","author":"Boasso","year":"2009","journal-title":"J Intern Med"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/INF.0000000000002183","article-title":"Vaccine strain varicella infection in an infant with previously undiagnosed perinatal human immunodeficiency type-1 infection.","volume":"38","author":"Farnaes","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1525-1470.2009.00942.x","article-title":"Disseminated varicella zoster virus in an immunized child as the acquired immunodeficiency syndrome-defining illness.","volume":"27","author":"Chilek","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"e0199229","DOI":"10.1371\/journal.pone.0199229","article-title":"Adverse events after vaccination among HIV-positive persons, 1990-2016.","volume":"13","author":"Su","year":"2018","journal-title":"PLoS One"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"ofz295","DOI":"10.1093\/ofid\/ofz295","article-title":"Varicella virus vaccine live: a 22-year review of postmarketing safety data.","volume":"6","author":"Woodward","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2013.10.027","article-title":"Disseminated vaccine-strain varicella as initial presentation of the acquired immunodeficiency syndrome: a case report and review of the literature.","volume":"59","author":"Maves","year":"2014","journal-title":"J Clin Virol"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhin.2017.05.024","article-title":"First case of vaccine-strain varicella infection as manifestation of HIV in healthcare worker: a case report and review of the literature.","volume":"97","author":"Navalkele","year":"2017","journal-title":"J Hosp Infect"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.inf.0000207492.97867.15","article-title":"Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.","volume":"25","author":"Armenian","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/QAD.0b013e3280113f29","article-title":"Varicella vaccination in HIV-1-infected children after immune reconstitution.","volume":"20","author":"Bekker","year":"2006","journal-title":"AIDS"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine.","volume":"139","author":"Levin","year":"2001","journal-title":"J Pediatr"},{"key":"R31-20260911","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/505149","article-title":"Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.","volume":"194","author":"Levin","year":"2006","journal-title":"J Infect Dis"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.hivar.2015.03.004","article-title":"Antibody response to VZV vaccination in HIV infected children.","volume":"14","author":"O\u0142dakowska","year":"2015","journal-title":"HIV AIDS Rev"},{"key":"R34-20260911","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/INF.0b013e3181fe0868","article-title":"The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.","volume":"30","author":"Taweesith","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20260911","first-page":"1","article-title":"1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age.","volume":"43","author":"Caldwell","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/jama.293.18.2213","article-title":"Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.","volume":"293","author":"Brogly","year":"2005","journal-title":"JAMA"},{"key":"R40-20260911","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/civ734","article-title":"Prevalence and persistence of varicella antibodies in previously immunized children and youth with perinatal HIV-1 infection.","volume":"62","author":"Purswani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R41-20260911","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1086\/652798","article-title":"Effectiveness of varicella vaccine in children infected with HIV.","volume":"201","author":"Son","year":"2010","journal-title":"J Infect Dis"},{"key":"R43-20260911","first-page":"93","article-title":"Varicella-zoster virus: prospects for control.","volume":"10","author":"Gershon","year":"1995","journal-title":"Adv Pediatr Infect Dis"},{"key":"R44-20260911","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R45-20260911","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations.","volume":"20","author":"Kim","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R46-20260911","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0b013e3181632cda","article-title":"Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.","volume":"48","author":"Vigano","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R47-20260911","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1468-1293.2006.00409.x","article-title":"Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"7","author":"Aurpibul","year":"2006","journal-title":"HIV Med"},{"key":"R48-20260911","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated?","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R49-20260911","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"key":"R50-20260911","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003-2014.","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"R51-20260911","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella vaccine collaborative study group.","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:00:54Z","timestamp":1789099254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005264"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005264","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]}}}